Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12P - Fermentation or enzyme-using processes to synthesise a desired chemical compound or composition or to separate optical isomers from a racemic mixture › C12P 21 - Preparation of peptides or proteins
Patents for C12P 21 - Preparation of peptides or proteins (112,499)
05/2000
05/10/2000EP0999277A1 Method for expression of recombinant proteins through the use of the effects of stress and stress-response mechanisms in the presence of compatible solutes
05/10/2000EP0999276A1 Method for the synthesis of extracellular proteins involving expression in heterologous bacterial hosts
05/10/2000EP0999273A1 HUMAN GENE RecQ4 ENCODING HELICASE
05/10/2000EP0999271A2 Retinoid receptor compositions and methods
05/10/2000EP0999268A1 New gene with upregulated expression in metastatic human tumor cells and a protein coded thereby, methods of production, and use thereof
05/10/2000EP0998583A1 Method of detecting thrombotic disease risk
05/10/2000EP0998582A1 Methods for diagnosis and treating cancers, and methods for identifying pathogenic markers in a sample of normal cells
05/10/2000EP0998576A2 Bovine adenovirus type 3 genome
05/10/2000EP0998573A2 Fusion proteins with an immunoglobulin hinge region linker
05/10/2000EP0998572A2 Aggrecan degrading metallo proteases
05/10/2000EP0998569A1 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells
05/10/2000EP0998561A1 Trail receptor
05/10/2000EP0998559A1 Mammalian secretory peptide-9
05/10/2000EP0998558A1 Wa545 compositions
05/10/2000EP0998556A2 Diagnosis and treatment of diseases using anti-t-cell receptor vbeta antibodies or peptides which are recognized by said antibodies, and endocrine secretion regulatory protein 1 (esrp1)
05/10/2000EP0998496A1 Isolated dendritic cell membrane protein genes
05/10/2000EP0998490A2 Secreted proteins and polynucleotides encoding them
05/10/2000EP0998486A1 Protein recovery by chromatography followed by filtration upon a charged layer
05/10/2000EP0840786A4 Gdu, a novel signalling protein
05/10/2000EP0725822B1 Process for the recombinant production of proteins in yeast
05/10/2000CN1252811A Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use as the rapentics
05/10/2000CN1252810A Antibody for inhibiting blood coagulation and method of use thereof
05/10/2000CN1252809A Modified TNF alpha molecules, DNA encoding such modified TNF alpha molecules and vaccines comprising such modified TNF alpha molecules and DNA
05/10/2000CN1252440A Avid kyowamycin regulation gene for improving disinsection mychel yield
05/09/2000US6060595 Inhibition of viral replication
05/09/2000US6060589 Agouti-related proteins
05/09/2000US6060588 Bap-1 proteins
05/09/2000US6060587 Cellular receptor for HIV-1 VPR essential for G2/M phase transition of the cell cycle
05/09/2000US6060307 Amino acid transporters and uses
05/09/2000US6060303 Use in screening assays and as pharmaceuticals.
05/09/2000US6060296 Protein kinases
05/09/2000US6060294 Alanyl tRNA synthetase from Staphylococcus aureus
05/09/2000US6060285 Process for the production of hetero-bispecific antibodies
05/09/2000US6060282 Streptococcus pneumoniae gene sequence Dpj
05/09/2000US6060280 Nucleotide sequences encoding bovine respiratory syncytial virus immunogenic proteins
05/09/2000US6060276 Nucleotide sequences for proteins involved in signal transduction; for assays to detect/measure ligands; diagnosis and therapy of endocrine disorders; gene therapy; antisense agents; transgenic animals
05/09/2000US6060274 Extracellular expression of cellulose binding domains (CBD) using Bacillus
05/09/2000US6060273 Multicistronic expression units and their use
05/09/2000US6060272 Human G-protein coupled receptors
05/09/2000US6060264 Multiple drug resistance gene atrc of Aspergillus nidulans
05/09/2000US6060259 Having molecular weight in presence of sodium dodecyl sulfate of between 44.5 and 47.5 kilodaltons; for detecting or monitoring the development of tuberculosis in man or cattle
05/09/2000US6060239 Cellubrevin homologs
05/09/2000US6060064 Chimeric virus-like particle antigen presentation and delivery system
05/09/2000US6060059 Haemophilus adhesion proteins
05/09/2000US6060057 Cloning and sequencing of allergens of Dermatophagoides (house dust mite)
05/09/2000US6060054 Product for T lymphocyte immunosuppression
05/09/2000US6060047 Co-administration of interleukin-3 mutant polypeptides with CSF's for multi-lineage hematopoietic cell production
05/09/2000US6060037 Conjugated compounds which comprise an st receptor binding moiety and a radiostable active moiety
05/09/2000CA2100586C Htlv-i and htlv-ii peptide antigens and methods
05/09/2000CA2057860C Immunoactive peptides and antibodies and their use in anti-allergy treatment
05/04/2000WO2000024937A2 Parallel methods for genomic analysis
05/04/2000WO2000024923A1 The enzyme-mediated synthesis of peptidomimetics
05/04/2000WO2000024922A1 Method for producing in vivo proteins chemically diversified by incorporating non-standard amino acids
05/04/2000WO2000024904A1 PLANT-OPTIMIZED POLYNUCLEOTIDES ENCODING APPROXIMATELY 15 kDa AND APPROXIMATELY 45 kDa PESTICIDAL PROTEINS
05/04/2000WO2000024902A1 Chlamydia antigens and corresponding dna fragments and uses thereof
05/04/2000WO2000024901A1 Chlamydia antigens and corresponding dna fragments and uses thereof
05/04/2000WO2000024899A2 Interleukin-1 homolog zil1a4
05/04/2000WO2000024890A1 Novel g protein-coupled receptor proteins, dnas thereof and ligands to the same
05/04/2000WO2000024889A1 Monoclonal antibodies against human apoptosis inhibitory protein naip and method for assaying naip
05/04/2000WO2000024886A1 Prv-1 gene and the use thereof
05/04/2000WO2000024873A1 Process for recovering heterologous polypeptides from bacterial cells
05/04/2000WO2000024782A2 Modified peptides, comprising an fc domain, as therapeutic agents
05/04/2000WO2000024781A1 Conformation-specific anti-von willebrand factor antibodies
05/04/2000WO2000024780A2 Compositions and methods for treating polycystic kidney disease
05/04/2000WO2000024779A1 Lysine-rich statherin protein
05/04/2000WO2000024776A1 Novel toll-like receptor and gene thereof
05/04/2000WO2000024773A2 Inhibition of transglutaminase-mediated microbial infection of a mammalian host
05/04/2000WO2000024771A2 Nucleic acids encoding osteoprotegerin-like proteins and methods of using same
05/04/2000WO2000024770A2 Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity
05/04/2000WO2000024769A2 Process for recovering heterologous polypeptide from bacterial refractile particles
05/04/2000WO2000024766A2 New transcription factor of mhc class ii genes, substances capable of inhibiting this new transcription factor and medical uses of these substances
05/04/2000WO2000024758A1 ISOLATED NUCLEIC ACID MOLECULES WHICH ENCODE T CELL INDUCIBLE FACTORS (TIFs), THE PROTEINS ENCODED, AND USES THEREOF
05/04/2000WO2000006743A3 Chlamydia antigens and corresponding dna fragments and uses thereof
05/04/2000WO2000006730A3 Human cytoskeletal proteins
05/04/2000WO2000005367A3 Human proteins having hydrophobic domains and dnas encoding these proteins
05/04/2000WO2000003009A3 Genes for the biosynthesis of anticapsin and bacilysine, their isolation and their use
05/04/2000WO2000002897B1 Delta cleavage products and methods based thereon
05/04/2000WO1999052944A8 G-protein coupled receptors
05/04/2000WO1999051781A9 Hepatitis c virus ns5b compositions and methods of use thereof
05/04/2000CA2356595A1 Monoclonal antibodies against human apoptosis inhibitory protein naip and method for assaying naip
05/04/2000CA2349211A1 Prv-1 gene and the use thereof
05/04/2000CA2348989A1 Chlamydia antigens and corresponding dna fragments and uses thereof
05/04/2000CA2348837A1 Methods for using co-regulated genesets to enhance detection and classification of gene expression patterns
05/04/2000CA2348747A1 Chlamydia antigens and corresponding dna fragments and uses thereof
05/04/2000CA2348683A1 Parallel methods for genomic analysis
05/04/2000CA2348563A1 Compositions and methods for treating polycystic kidney disease
05/04/2000CA2348431A1 Interleukin-1 homolog zil1a4
05/04/2000CA2348046A1 Lysine-rich statherin protein
05/04/2000CA2347993A1 Method for producing in vivo proteins chemically diversified by incorporating non-standard amino acids
05/04/2000CA2347983A1 Inhibition of transglutaminase-mediated microbial infection of a mammalian host
05/04/2000CA2347294A1 Novel g protein coupled receptor protein, dna and its ligand
05/04/2000CA2347293A1 Nucleic acids encoding osteoprotegerin-like proteins and methods of using same
05/04/2000CA2347068A1 New transcription factor of mhc class ii genes, substances capable of inhibiting this new transcription factor and medical uses of these substances
05/04/2000CA2346996A1 Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity
05/04/2000CA2344606A1 Conformation-specific anti-von willebrand factor antibodies
05/04/2000CA2249648A1 Mammalian subtilisin/kexin isozyme ski-1: a proprotein convertase with a unique cleavage specificity
05/03/2000EP0997529A2 Feline immunodeficiency virus strain FIV-141 and uses thereof
05/03/2000EP0997528A1 Streptomyces avermitilis regulatory genes for increased avermectin production
05/03/2000EP0997477A2 MHC complexes and uses thereof
05/03/2000EP0997476A2 Antibodies to a mammalian Langerhans cell antigen and their uses
1 ... 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 ... 1125